IT1250672B - Formulazioni orali di ubidecarenone in soluzione acquosa - Google Patents

Formulazioni orali di ubidecarenone in soluzione acquosa

Info

Publication number
IT1250672B
IT1250672B ITMI911919A ITMI911919A IT1250672B IT 1250672 B IT1250672 B IT 1250672B IT MI911919 A ITMI911919 A IT MI911919A IT MI911919 A ITMI911919 A IT MI911919A IT 1250672 B IT1250672 B IT 1250672B
Authority
IT
Italy
Prior art keywords
ubidecarenone
aqueous solution
oral formulations
active ingredient
castor oil
Prior art date
Application number
ITMI911919A
Other languages
English (en)
Inventor
Roberto Seghizzi
Giuseppe Furiosi
Ernesto Marco Martinelli
Giorgio Pifferi
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Priority to ITMI911919A priority Critical patent/IT1250672B/it
Publication of ITMI911919A0 publication Critical patent/ITMI911919A0/it
Priority to EP92111140A priority patent/EP0522433A1/en
Priority to FR9208096A priority patent/FR2678836B1/fr
Priority to JP4204214A priority patent/JPH05186340A/ja
Priority to CH2169/92A priority patent/CH684629A5/fr
Priority to KR1019920012250A priority patent/KR930001903A/ko
Publication of ITMI911919A1 publication Critical patent/ITMI911919A1/it
Application granted granted Critical
Publication of IT1250672B publication Critical patent/IT1250672B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Vengono descritte formulazioni farmaceutiche, in forma di soluzioni acquose ad uso orale, contenenti come principio attivo ubidecarenone, caratterizzate dal fatto che contengono come tensioattivo non ionico olio di ricino idrogenato polietossilato 40.
ITMI911919A 1991-07-11 1991-07-11 Formulazioni orali di ubidecarenone in soluzione acquosa IT1250672B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI911919A IT1250672B (it) 1991-07-11 1991-07-11 Formulazioni orali di ubidecarenone in soluzione acquosa
EP92111140A EP0522433A1 (en) 1991-07-11 1992-07-01 Oral aqueous solutions containing ubidecarenone
FR9208096A FR2678836B1 (fr) 1991-07-11 1992-07-01 Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses.
JP4204214A JPH05186340A (ja) 1991-07-11 1992-07-09 水性溶液形態のユビキノン含有経口製剤
CH2169/92A CH684629A5 (fr) 1991-07-11 1992-07-09 Formulations pour voie orale d'ubidécarénone sous la forme de solutions aqueuses.
KR1019920012250A KR930001903A (ko) 1991-07-11 1992-07-09 유비데카레논 경구용 수용액 제제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911919A IT1250672B (it) 1991-07-11 1991-07-11 Formulazioni orali di ubidecarenone in soluzione acquosa

Publications (3)

Publication Number Publication Date
ITMI911919A0 ITMI911919A0 (it) 1991-07-11
ITMI911919A1 ITMI911919A1 (it) 1993-01-11
IT1250672B true IT1250672B (it) 1995-04-21

Family

ID=11360324

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911919A IT1250672B (it) 1991-07-11 1991-07-11 Formulazioni orali di ubidecarenone in soluzione acquosa

Country Status (6)

Country Link
EP (1) EP0522433A1 (it)
JP (1) JPH05186340A (it)
KR (1) KR930001903A (it)
CH (1) CH684629A5 (it)
FR (1) FR2678836B1 (it)
IT (1) IT1250672B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051643B1 (es) * 1992-10-13 1995-02-16 Inverni Della Beffa Farma Formulaciones orales de ubidecarenona en forma de soluciones acuosas.
ES2074395B1 (es) * 1993-02-25 1996-03-01 Lifepharma Srl Composicion farmaceutica o dietetica de elevada actividad antioxidante en las patologias cardiovasculares y/o hepaticas.
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
US6054261A (en) * 1998-05-20 2000-04-25 Q-Pharma, Inc. Coenzyme Q10 compositions for organ protection during perfusion
JP3742602B2 (ja) * 2001-05-09 2006-02-08 株式会社カネカ 還元型補酵素ｑの安定な溶液
CA2451163A1 (en) * 2001-06-28 2003-01-09 Takeda Chemical Industries, Ltd. Agent for preventing or treating organ functional disorders and order dysfunction
JP3549197B2 (ja) 2001-08-10 2004-08-04 日清ファルマ株式会社 ユビキノン含有製剤
JP3822479B2 (ja) 2001-10-10 2006-09-20 株式会社カネカ 還元型補酵素ｑ水溶液の安定化組成
JP4970734B2 (ja) * 2005-03-03 2012-07-11 株式会社コーセー 透明水性組成物
KR100859781B1 (ko) * 2007-03-26 2008-09-24 (주)미토콘 유비데카레논-함유 약학 조성물
PE20130045A1 (es) 2010-03-12 2013-01-28 Berg Pharma Llc FORMULACIONES INTRAVENOSAS DE COENZIMA Q10 (CoQ10) Y METODOS DE USO DE LAS MISMAS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1334961A (fr) * 1961-03-06 1963-08-16 Merck & Co Inc Solutions aqueuses stables à base de benzoquinone substituée
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
CH667387A5 (it) * 1985-12-24 1988-10-14 Seuref Ag Formulazioni farmaceutiche acquose di ubichinone.
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液

Also Published As

Publication number Publication date
JPH05186340A (ja) 1993-07-27
KR930001903A (ko) 1993-02-22
FR2678836B1 (fr) 1995-06-09
ITMI911919A1 (it) 1993-01-11
CH684629A5 (fr) 1994-11-15
EP0522433A1 (en) 1993-01-13
FR2678836A1 (fr) 1993-01-15
ITMI911919A0 (it) 1991-07-11

Similar Documents

Publication Publication Date Title
EP1100522A4 (en) ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
TR199901077A2 (en) �spen�iyari form�lasyonlar.
ZA200000603B (en) Use of stilbene derivatives substituted in position 3, as deodrorant active agents in cosmetic compositions.
ATE321534T1 (de) Verbesserte liposomale formulierung
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
ATE245900T1 (de) Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
DE59102620D1 (de) Feste orale Applikationsformen, die als Wirkstoff Ifosfamid enthalten.
DE69207777D1 (de) Körperpflegemittel
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
YU87501A (sh) Farmaceutski kompleksi
ES2059756T3 (es) Composiciones farmaceuticas que contienen primicina.
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
HRP20000703B1 (hr) Stabilni pripravci koji sadrže levosimendan i alginsku kiselinu
DE69007956D1 (de) Antischwundadditiv enthaltender Dentalwirkstoff.
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
ES2087178T3 (es) Disulfato de ws7622a, procedimiento para su preparacion y su uso.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730